No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
LANV Lanvin Group
- 1.613
- -0.048-2.86%
Close May 21 16:00 ET
- 1.550
- -0.063-3.88%
Pre 08:32 ET
233.85MMarket Cap-891P/E (TTM)
1.630High1.540Low57.10KVolume1.550Open1.660Pre Close88.87KTurnover0.10%Turnover RatioLossP/E (Static)145.02MShares6.00052wk High0.90P/B96.01MFloat Cap1.27052wk Low--Dividend TTM59.54MShs Float22.810Historical High--Div YieldTTM5.42%Amplitude1.270Historical Low1.556Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
LAZR and RERE Among Consumer Discretionary Movers
Lanvin Group Holdings Reports FY Results; Reaffirms Full-year Outlook
Earnings Call Summary | Lanvin Group(LANV.US) Q4 2023 Earnings Conference
The following is a summary of the Lanvin Group Holdings Limited (LANV) Q4 2023 Earnings Call Transcript:Financial Performance:Lanvin Group reported a revenue of €426 million in 2023, marking a 1% grow
Express News | Lanvin Group Shows Resiliency in Sales and on-Track Margin Improvement in 2023
Lanvin Group to Report 2023 Full-Year Audited Results on April 30, 2024
Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, will release its audited results for the full-year 2023 on Tuesday, April 30,...
BYON and EJH Among Consumer Discretionary Movers
Comments
Eric Chan's vast real estate and consumer experience are predicted to steer the next phase of Lanvin Group's growth and international expansion, leveraging its experienced leaders and clear creative direction.
Press Release: Lanvin Group Announces New CEO
$AMC Entertainment(AMC.US$
$SaverOne 2014(SVRE.US$
$Apollomics(APLM.US$
$Alpine Summit Energy Partners(ALPSQ.US$
$Mangoceuticals(MGRX.US$
$Advanced Health Intelligence(AHI.US$
$Lanvin Group(LANV.US$
$Heart Test Laboratories(HSCS.US$
$Mobilicom(MOB.US$
$Trxade Health(MEDS.US$
$Gorilla Technology(GRRR.US$
$OKYO Pharma(OKYO.US$
$Cadrenal Therapeutics(CVKD.US$
$BullFrog AI(BFRG.US$
$VCI Global(VCIG.US$
...
$SaverOne 2014(SVRE.US$
$Apollomics(APLM.US$
$Alpine Summit Energy Partners(ALPSQ.US$
$Mangoceuticals(MGRX.US$
$Advanced Health Intelligence(AHI.US$
$Lanvin Group(LANV.US$
$Heart Test Laboratories(HSCS.US$
$Mobilicom(MOB.US$
$Trxade Health(MEDS.US$
$Gorilla Technology(GRRR.US$
$OKYO Pharma(OKYO.US$
$Cadrenal Therapeutics(CVKD.US$
$BullFrog AI(BFRG.US$
$VCI Global(VCIG.US$
...
7
9
1
1
$Lanvin Group(LANV.US$ bought in at 5.55
$Lanvin Group(LANV.US$ love this reversal to the upside rest of week.
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg